默沙东中国区收入同比下滑70%。

医药财经
Aug 02, 2025

默沙东HPV疫苗Gardasil(佳达修)全球销售额在2025年第二季度暴跌55%,Q2中国区整体收入同比下滑70%,引发其全球业绩下滑及大规模重组。这一结果并非仅因短期供需波动,而是市场环境、竞争格局与公司策略共同作用下的必然趋势。医药财经AI结合公开信息,分析如下:一、业绩暴跌的核心数据1. 中国市场拖累全球表现Gardasil全球Q2销售额仅11亿美元,同比暴跌55%,其中中国市场是最大拖累...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10